Small Molecule Outsourcing STREAM

  1. How To Design An HPAPI Plant And Its Containment Systems

    Dr. Friederike Hermann, head of occupational hygiene and biosafety, shares her expertise on requirements and evaluating the right containment that meets the needs of all process steps and stakeholders.

  2. Accelerating Clinical Development: Modern Tools In Process Chemistry 1/23/2025

    Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.

  3. Achieving Desired Particle Size And Yield Through Efficient Micronization 1/22/2025

    In this webinar, experts examine how the right combination of advanced technology and specialized expertise can leverage micronization to address the challenges often faced by small molecule drugs.

  4. Dramatic Reduction Of Solvent Usage In Pharmaceutical Spray Drying

    Using volatile processing aids to increase drug solubility in more environmentally friendly solvents, like methanol, reduces the amount of solvent required to manufacture amorphous solid dispersions (ASDs).

  5. How To Deal With The Complexity Of Drugs In Clinical Development

    Discover how to advance new compounds with complex chemistry through each stage of development by refining processes to give fit-for-purpose manufacturability and yields.

  6. CESS Technology 10/20/2020

    Learn how the award-winning CESS® technology can be used in Nanoforming™ future medicines to increase bioavailability for molecules with poor solubility.

  7. Cambrex Scientist Spotlight: Shawn Conway 1/29/2025

    Shawn Conway, Senior Director of Operations in High Point, NC, leads a dynamic team of engineers and chemists at Cambrex, focused on supporting clients throughout the entire product life cycle.

  8. Collaboration Across Cambrex 1/29/2025

    Our collaborative environment ensures efficient project execution and thorough product testing across multiple sites, consistently delivering client satisfaction.

  9. The Future Of Oral Solid Dose Development And Innovation 2/27/2025

    Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.

  10. Challenges Of Moving A Bioconjugate Candidate From Clinic To Market

    Drug developers must successfully navigate the path to market, under the growing pressure of regulation and competition, and while carefully managing technical and financial risk.